BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Däbritz J, Musci J, Foell D. Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome. World J Gastroenterol 2014; 20(2): 363-375 [PMID: 24574706 DOI: 10.3748/wjg.v20.i2.363]
URL: https://www.wjgnet.com/1007-9327/full/v20/i2/363.htm
Number Citing Articles
1
Elena A. Usacheva, Jian-P. Jin, Lance R. Peterson. Host response to Clostridium difficile infection: Diagnostics and detectionJournal of Global Antimicrobial Resistance 2016; 7: 93 doi: 10.1016/j.jgar.2016.08.002
2
R. Carmona-Sánchez, M.E. Icaza-Chávez, M.V. Bielsa-Fernández, O. Gómez-Escudero, F. Bosques-Padilla, E. Coss-Adame, F. Esquivel-Ayanegui, Á.R. Flores-Rendón, M.A. González-Martínez, F. Huerta-Iga, A. López-Colombo, T.H. Méndez-Gutiérrez, A. Noble-Lugo, J.R. Nogueira-de Rojas, R.H. Raña-Garibay, J.M. Remes-Troche, F. Roesch-Dietlen, M.J. Schmulson, J.C. Soto-Pérez, J.L. Tamayo, L.F. Uscanga, M.Á. Valdovinos, J. Valerio-Ureña, M.R. Zavala-Solares. Consenso mexicano sobre el síndrome de intestino irritableRevista de Gastroenterología de México 2016; 81(3): 149 doi: 10.1016/j.rgmx.2016.01.004
3
Pengpeng Xia, Xin Ma, Li Yan, Siqi Lian, Xiangyu Li, Yi Luo, Ziyue Chen, Xingduo Ji. Generation and Application of Monoclonal Antibodies against Porcine S100A8, S100A9, and S100A12 Proteins Using Hybridoma TechnologyInternational Journal of Molecular Sciences 2024; 25(2): 1029 doi: 10.3390/ijms25021029
4
Andreas Sturm, Raja Atreya, Dominik Bettenworth, Bernd Bokemeyer, Axel Dignaß, Robert Ehehalt, Christoph Germer, Philip C. Grunert, Ulf Helwig, Klaus Herrlinger, Peter Kienle, Martin E. Kreis, Torsten Kucharzik, Jost Langhorst, Christian Maaser, Johann Ockenga, Claudia Ott, Britta Siegmund, Sebastian Zeißig, Andreas Stallmach. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004Zeitschrift für Gastroenterologie 2022; 60(03): 332 doi: 10.1055/a-1713-3941
5
Pengpeng Xia, Xingduo Ji, Li Yan, Siqi Lian, Ziyue Chen, Yi Luo. Roles of S100A8, S100A9 and S100A12 in infection, inflammation and immunityImmunology 2024; 171(3): 365 doi: 10.1111/imm.13722
6
Ishita Mostafa, Rahvia Alam Sthity, Umme Habiba Lamiya, Md. Tariqujjaman, Mustafa Mahfuz, S. M. Tafsir Hasan, Tahmeed Ahmed. Effect of Gut Microbiota-Directed Complementary Food Supplementation on Fecal and Plasma Biomarkers of Gut Health and Environmental Enteric Dysfunction in Slum-Dwelling Children with Moderate Acute MalnutritionChildren 2024; 11(1): 69 doi: 10.3390/children11010069
7
Reza Ranjbar, Mohamad Ghasemian, Mahmood Maniati, Seyyed Hossein Khatami, Navid Jamali, Mortaza Taheri-Anganeh. Gastrointestinal disorder biomarkersClinica Chimica Acta 2022; 530: 13 doi: 10.1016/j.cca.2022.02.013
8
S Ho, K Woodford, S Kukuljan, S Pal. Comparative effects of A1 versus A2 beta-casein on gastrointestinal measures: a blinded randomised cross-over pilot studyEuropean Journal of Clinical Nutrition 2014; 68(9): 994 doi: 10.1038/ejcn.2014.127
9
T. Sagawa, S. Kakizaki, T. Tomizawa, T. Nakayama, H. Tanaka, H. Tojima, K. Sato, M. Kusano, S. Okamura, M. Yamada. Faecal lactoferrin is a useful biomarker for mucosal healing in patients with ulcerative colitis during granulocyte and monocyte adsorptive apheresis therapyColorectal Disease 2016; 18(7): 696 doi: 10.1111/codi.13258
10
Christian Syukur, Bradley Jimmy Waleleng, Fandy Gosal, Luciana Sophie Mariana Rotty, Jeanne Winarta, Andrew Waleleng. Tumor Necrosis Factor-α, Fecal Calprotectin, and Disease Activity in Inflammatory Bowel Disease PatientsOpen Access Macedonian Journal of Medical Sciences 2023; 11(B): 346 doi: 10.3889/oamjms.2023.11284
11
Nicholas J Talley. Evolution of the Diagnosis of Functional Gut Disorders: Is an Objective Positive Diagnostic Approach Within Reach?Clinical and Translational Gastroenterology 2015; 6(7): e104 doi: 10.1038/ctg.2015.29
12
Dandan Liu, Varma Saikam, Katie A. Skrada, Didier Merlin, Suri S. Iyer. Inflammatory bowel disease biomarkersMedicinal Research Reviews 2022; 42(5): 1856 doi: 10.1002/med.21893
13
Byung Chang Kim, Jungnam Joo, Hee Jin Chang, Hyun Yang Yeo, Byong Chul Yoo, Boram Park, Ji Won Park, Dae Kyung Sohn, Chang Won Hong, Kyung Su Han, John Souglakos. A Predictive Model Combining Fecal Calgranulin B and Fecal Occult Blood Tests Can Improve the Diagnosis of Colorectal CancerPLoS ONE 2014; 9(9): e106182 doi: 10.1371/journal.pone.0106182
14
Carlos Teruel, Elena Garrido, Francisco Mesonero. Diagnosis and management of functional symptoms in inflammatory bowel disease in remissionWorld Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(1): 78-90 doi: 10.4292/wjgpt.v7.i1.78
15
Maxime M.W. De Sloovere, Dieter De Smet, Filip J. Baert, Johan Debrabandere, Hilde J.M. Vanpoucke. Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel diseaseClinical Chemistry and Laboratory Medicine (CCLM) 2017; 55(9) doi: 10.1515/cclm-2016-0796
16
Magdy El-Salhy. Recent advances in the diagnosis of irritable bowel syndromeExpert Review of Gastroenterology & Hepatology 2015; 9(9): 1161 doi: 10.1586/17474124.2015.1067138
17
Mariana del Rocio Ruiz-Briseño, Judith Carolina De Arcos-Jiménez, Sarah Ratkovich-González, Karina Sánchez-Reyes, Luz A. González-Hernández, Jaime F. Andrade-Villanueva, Monserrat Alvarez-Zavala. Association of intestinal and systemic inflammatory biomarkers with immune reconstitution in HIV+ patients on ARTJournal of Inflammation 2020; 17(1) doi: 10.1186/s12950-020-00262-4
18
Qihong Yu, Xinru Liu, Haojie Huang, Xingfeng Zheng, Xue Pan, Junwei Fang, Liyuan Meng, Chunhua Zhou, Xiaocui Zhang, Zhaoshen Li, Duowu Zou. Mass spectrometry-based metabolomics for irritable bowel syndrome biomarkersTherapeutic Advances in Gastroenterology 2019; 12: 175628481988642 doi: 10.1177/1756284819886425
19
Ahmed M I Elfiky, Mohammed Ghiboub, Andrew Y F Li Yim, Ishtu L Hageman, Jan Verhoeff, Manon de Krijger, Patricia H P van Hamersveld, Olaf Welting, Iris Admiraal, Shafaque Rahman, Juan J Garcia-Vallejo, Manon E Wildenberg, Laura Tomlinson, Richard Gregory, Inmaculada Rioja, Rab K Prinjha, Rebecca C Furze, Huw D Lewis, Palwinder K Mander, Sigrid E M Heinsbroek, Matthew J Bell, Wouter J de Jonge. Carboxylesterase-1 Assisted Targeting of HDAC Inhibitors to Mononuclear Myeloid Cells in Inflammatory Bowel DiseaseJournal of Crohn's and Colitis 2022; 16(4): 668 doi: 10.1093/ecco-jcc/jjab176
20
Shiro Nakamura, Hirotsugu Imaeda, Hiroki Nishikawa, Masaki Iimuro, Minoru Matsuura, Hideo Oka, Junsuke Oku, Takako Miyazaki, Hirohito Honda, Kenji Watanabe, Hiroshi Nakase, Akira Andoh. Usefulness of fecal calprotectin by monoclonal antibody testing in adult Japanese with inflammatory bowel diseases: a prospective multicenter studyIntestinal Research 2018; 16(4): 554 doi: 10.5217/ir.2018.00027
21
Lucyna Ostrowska, Diana Wasiluk, Camille F. J. Lieners, Mirosława Gałęcka, Anna Bartnicka, Dag Tveiten. Igg Food Antibody Guided Elimination-Rotation Diet Was More Effective than FODMAP Diet and Control Diet in the Treatment of Women with Mixed IBS—Results from an Open Label StudyJournal of Clinical Medicine 2021; 10(19): 4317 doi: 10.3390/jcm10194317
22
M. Camilleri, A. Shin, I. Busciglio, P. Carlson, A. Acosta, A. E. Bharucha, D. Burton, J. Lamsam, A. Lueke, L. J. Donato, A. R. Zinsmeister. Validating biomarkers of treatable mechanisms in irritable bowel syndromeNeurogastroenterology & Motility 2014; 26(12): 1677 doi: 10.1111/nmo.12421
23
Rebecca K. Campbell, Kerry J. Schulze, Saijuddin Shaikh, Rubhana Raqib, Lee S. F. Wu, Hasmot Ali, Sucheta Mehra, Keith P. West, Parul Christian. Environmental enteric dysfunction and systemic inflammation predict reduced weight but not length gain in rural Bangladeshi childrenBritish Journal of Nutrition 2018; 119(4): 407 doi: 10.1017/S0007114517003683
24
Jan Däbritz, Patrick Gerner, Axel Enninger, Martin Claßen, Michael Radke. Inflammatory Bowel Disease in Childhood and AdolescenceDeutsches Ärzteblatt international 2017;  doi: 10.3238/arztebl.2017.0331
25
Jason Orlando Dimitri Musci, Jack Stephen Cornish, Jan Däbritz. Utility of surrogate markers for the prediction of relapses in inflammatory bowel diseasesJournal of Gastroenterology 2016; 51(6): 531 doi: 10.1007/s00535-016-1191-3
26
Mark D. Gonzalez, Craig B. Wilen, Carey-Ann D. Burnham. Markers of Intestinal Inflammation for the Diagnosis of Infectious GastroenteritisClinics in Laboratory Medicine 2015; 35(2): 333 doi: 10.1016/j.cll.2015.02.001
27
Saranya Kittanakom, Md. Sharif Shajib, Kristine Garvie, Joceline Turner, Dan Brooks, Sufian Odeh, Robert Issenman, V. Tony Chetty, Joseph Macri, Waliul I. Khan. Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel DiseaseCanadian Journal of Gastroenterology and Hepatology 2017; 2017: 1 doi: 10.1155/2017/1450970
28
Mohammed Amin Mohammed, Alaa Mahamad A. Hakeem , Nesreen Moustafa Omar, Abdelhadi M. Shebl, Amany H. Mansour, Sherin Mohamed Abd El-Azi, Gamal Othman, Soad Amin Mohammed. Faecal Calgranulin C Versus Faecal Calprotectin as Non Invasive Markers Distinguishing Functional From Organic Causes of Chronic DiarrheaJournal of Medical Sciences 2014; 14(4): 179 doi: 10.3923/jms.2014.179.191
29
Mohsen Hanifeh, Minna Marjaana Rajamäki, Pernilla Syrjä, Laura Mäkitalo, Susanne Kilpinen, Thomas Spillmann. Identification of matrix metalloproteinase-2 and -9 activities within the intestinal mucosa of dogs with chronic enteropathiesActa Veterinaria Scandinavica 2018; 60(1) doi: 10.1186/s13028-018-0371-y
30
Catherine Colman, Marlene Stone, Alain Bitton. Inflammatory Bowel Disease Nursing Manual2019; : 43 doi: 10.1007/978-3-319-75022-4_6
31
James P. Campbell, Claudia Zierold, Ashli M. Rode, Frank A. Blocki, Byron P. Vaughn. Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel SyndromeJournal of Clinical Gastroenterology 2021; 55(3): 239 doi: 10.1097/MCG.0000000000001359
32
Athanasios Tsigaridas, Ioannis S. Papanikolaou, Anna Vaiopoulou, Athanasios K. Anagnostopoulos, Nikos Viazis, George Karamanolis, Dimitrios G. Karamanolis, George T. Tsangaris, Gerasimos J. Mantzaris, Maria Gazouli. Proteomics and irritable bowel syndromeExpert Review of Proteomics 2017; 14(5): 461 doi: 10.1080/14789450.2017.1317600
33
Marisol Garzón, Luis Pereira-da-Silva, Jorge Seixas, Ana Luísa Papoila, Marta Alves, Filipa Ferreira, Ana Reis. Association of enteric parasitic infections with intestinal inflammation and permeability in asymptomatic infants of São Tomé IslandPathogens and Global Health 2017; 111(3): 116 doi: 10.1080/20477724.2017.1299831
34
Marek Waluga. A Comprehensive Overview of Irritable Bowel Syndrome2020; : 107 doi: 10.1016/B978-0-12-821324-7.00009-5
35
Rebecca K. Campbell, Kerry J. Schulze, Saijuddin Shaikh, Sucheta Mehra, Hasmot Ali, Lee Wu, Rubhana Raqib, Sarah Baker, Alain Labrique, Keith P. West, Parul Christian. Biomarkers of Environmental Enteric Dysfunction Among Children in Rural BangladeshJournal of Pediatric Gastroenterology and Nutrition 2017; 65(1): 40 doi: 10.1097/MPG.0000000000001557
36
Anke Heida, Anneke C. Muller Kobold, Lucie Wagenmakers, Koos van de Belt, Patrick F. van Rheenen. Reference values of fecal calgranulin C (S100A12) in school aged children and adolescentsClinical Chemistry and Laboratory Medicine (CCLM) 2017; 56(1): 126 doi: 10.1515/cclm-2017-0152
37
Paul A. S. Olsen, Reidar Fossmark, Gunnar Qvigstad. Fecal calprotectin in patients with suspected small bowel disease – a selection tool for small bowel capsule endoscopy?Scandinavian Journal of Gastroenterology 2015; 50(3): 272 doi: 10.3109/00365521.2014.1003395
38
Sanja Dragasevic, Biljana Stankovic, Nikola Kotur, Aleksandra Sokic Milutinovic, Tamara Milovanovic, Milica Stojkovic Lalosevic, Maja Stojanovic, Sonja Pavlovic, Dragan Popovic. Genetic Aspects of Micronutrients Important for Inflammatory Bowel DiseaseLife 2022; 12(10): 1623 doi: 10.3390/life12101623
39
Shah Mohammad Fahim, Subhasish Das, Md. Amran Gazi, Mustafa Mahfuz, Tahmeed Ahmed. Association of intestinal pathogens with faecal markers of environmental enteric dysfunction among slum‐dwelling children in the first 2 years of life in BangladeshTropical Medicine & International Health 2018; 23(11): 1242 doi: 10.1111/tmi.13141
40
Prokopis Konstanti, Marloes van Splunter, Erik van den Brink, Clara Belzer, Arjen Nauta, R. van Neerven, Hauke Smidt. The Effect of Nutritional Intervention with Lactoferrin, Galactooligosacharides and Vitamin D on the Gut Microbiota Composition of Healthy Elderly WomenNutrients 2022; 14(12): 2468 doi: 10.3390/nu14122468
41
Ewa Skarżyńska, Joanna Żytyńska-Daniluk, Barbara Lisowska-Myjak. Meconium lactoferrin levels in neonates: can we predefine normal values?The Journal of Maternal-Fetal & Neonatal Medicine 2017; 30(3): 279 doi: 10.3109/14767058.2016.1171307
42
Mark C. Anderson, Thibault Chaze, Yves-Marie Coïc, Louise Injarabian, Friederike Jonsson, Naelle Lombion, Dorothée Selimoglu-Buet, Judith Souphron, Caroline Ridley, Pascale Vonaesch, Bruno Baron, Ellen T. Arena, Jean-Yves Tinevez, Giulia Nigro, Katharina Nothelfer, Eric Solary, Valérie Lapierre, Thierry Lazure, Mariette Matondo, David Thornton, Philippe J. Sansonetti, Françoise Baleux, Benoit S. Marteyn. MUB40 Binds to Lactoferrin and Stands as a Specific Neutrophil MarkerCell Chemical Biology 2018; 25(4): 483 doi: 10.1016/j.chembiol.2018.01.014
43
Qing Xiao, Fengting Yu, Liting Yan, Hongxin Zhao, Fujie Zhang. Alterations in circulating markers in HIV/AIDS patients with poor immune reconstitution: Novel insights from microbial translocation and innate immunityFrontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1026070
44
Taojun He, Samuel E. Kaplan, Luz A. Gomez, Xuedong Lu, Lakshmi V. Ramanathan, Mini Kamboj, Yi-Wei Tang. Fecal calprotectin concentrations in cancer patients with Clostridium difficile infectionEuropean Journal of Clinical Microbiology & Infectious Diseases 2018; 37(12): 2341 doi: 10.1007/s10096-018-3381-9
45
Dorota Roszak, Mirosława Gałęcka, Wojciech Cichy, Patrycja Szachta. Determination of faecal inflammatory marker concentration as a noninvasive method of evaluation of pathological activity in children with inflammatory bowel diseasesAdvances in Medical Sciences 2015; 60(2): 246 doi: 10.1016/j.advms.2015.04.003
46
R. Carmona-Sánchez, M.E. Icaza-Chávez, M.V. Bielsa-Fernández, O. Gómez-Escudero, F. Bosques-Padilla, E. Coss-Adame, F. Esquivel-Ayanegui, Á.R. Flores-Rendón, M.A. González-Martínez, F. Huerta-Iga, A. López-Colombo, T.H. Méndez-Gutiérrez, A. Noble-Lugo, J.R. Nogueira-de Rojas, R.H. Raña-Garibay, J.M. Remes-Troche, F. Roesch-Dietlen, M.J. Schmulson, J.C. Soto-Pérez, J.L. Tamayo, L.F. Uscanga, M.Á. Valdovinos, J. Valerio-Ureña, M.R. Zavala-Solares. The Mexican consensus on irritable bowel syndromeRevista de Gastroenterología de México (English Edition) 2016; 81(3): 149 doi: 10.1016/j.rgmxen.2016.01.004
47
Pasquale Mansueto, Alberto D’Alcamo, Aurelio Seidita, Antonio Carroccio. Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivityWorld Journal of Gastroenterology 2015; 21(23): 7089-7109 doi: 10.3748/wjg.v21.i23.7089
48
Filippo Vernia, Angelo Viscido, Mirko Di Ruscio, Gianpiero Stefanelli, Marco Valvano, Giovanni Latella. Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn’s Disease: Do They Still Have a Potential Clinical Role?Digestion 2021; 102(6): 833 doi: 10.1159/000518419
49
Ulf Helwig. Pflege bei chronisch-entzündlichen Darmerkrankungen2023; : 79 doi: 10.1007/978-3-662-64938-1_7
50
Cristina Romero-Mascarell, Gloria Fernández-Esparrach, Cristina Rodríguez-De Miguel, Maria Carme Masamunt, Sonia Rodríguez, Jordi Rimola, Miguel Urpí, Gherzon Simon Casanova, Ingrid Ordás, Elena Ricart, Berta Caballol, Agnès Fernández-Clotet, Julià Panés, Josep Llach, Begoña González-Suárez. Fecal Calprotectin for Small Bowel Crohn’s Disease: Is It a Cutoff Issue?Diagnostics 2022; 12(9): 2226 doi: 10.3390/diagnostics12092226